Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.

@article{Gupta2018NeoadjuvantCF,
  title={Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.},
  author={Sudeep Gupta and Amita Maheshwari and Pallavi Parab and Umesh M Mahantshetty and Rohini W. Hawaldar and Supriya Sastri Chopra and Rajendra A. Kerkar and Reena Engineer and Hemant B. Tongaonkar and Jaya Ghosh and Seema Gulia and Neha Kumar and T Surappa Shylasree and Renuka Gawade and Yogesh Kembhavi and Madhuri Gaikar and Santosh Menon and Meenakshi Haresh Thakur and Shyam Kishore Shrivastava and Rajendra A. Badwe},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2018},
  volume={36 16},
  pages={1548-1555}
}
Purpose We compared the efficacy and toxicity of neoadjuvant chemotherapy followed by radical surgery versus standard cisplatin-based chemoradiation in patients with locally advanced squamous cervical cancer. Patients and Methods This was a single-center, phase III, randomized controlled trial ( ClinicalTrials.gov identifier: NCT00193739). Eligible patients… CONTINUE READING